Early cancer detection saves lives through screening tests like mammography, HPV testing, and low-dose CT scans, improving ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the publication of a ...

Urine DNA fragments could act as health fingerprints, offering a non-invasive way to monitor immunity, detect diseases, and ...

A free research study at Nebraska Medicine is offering you the chance to learn how your genetics could impact your health.

For Breast Cancer Awareness Month, TODAY's Jill Martin brought together participants to sign up for genetic tests for breast ...

(NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the publication of a peer-reviewed manuscript in the Journal of Clinical Oncology - Precision Oncology (JCO PO) ...

The accuracy of non-invasive blood and stool-based tests for colorectal cancer is improving, but experts say it’s too soon to ...

The FDA has approved a new subcutaneous (SC) formulation of pembrolizumab (Keytruda Qlex), co-formulated with ...

In tissue biopsies, cancer cells are frequently observed to have nuclei (the cell's genetic information storage) larger than ...

New research from University of Delaware RNA biologist Mona Batish and colleagues shows circular RNA is favored for transport between cells. The research finding could hold important clues for ...

DelveInsight's DNA Synthesis Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report includes a ...

Pharmacogenomic testing can tell how a drug is likely to work in a certain person. But is it ready for rolling out to the ...